Tessera

🚀 One week to go! Real talk on entrepreneurship, with a founder, startup enabler, and venture consultant sharing what it really takes. What Does it Take to be an Entrepreneur Soumya Palliyil • Alessandro Mazzetti • Thomas Meier Save your spot ➡️ buff.ly/uWkJi1J

The wait is over 🚀 We’re happy to announce the ventures awarded Stage I by the INCATE Selection Committee! Congratulations to: 🔹 AFFIRMA BIOTECH SL 🔹 AstralytiX 🔹 i-Seq Biotechnology 🔹 Technische Universität Berlin 🔹 University of Auckland 🔹 Università di Pavia Read more ➡️

From discussion to discovery: meet INCATE’s new Stage I ventures - INCATE

For the first time, INCATE’s Selection Committee didn’t simply meet — they came together in person at the headquarters of one of our industry partners, creating an atmosphere in Munich filled with…

buff.ly

A new antibiotic hidden in a silent gene cluster — active against MRSA and VRSA. What else are bacteria hiding in genomes we’ve barely explored? Researchers uncovered **biffamycin A** using genome mining + synthetic biology. Read ➡️

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A

Genetic de-regulation of a silent biosynthetic pathway allowed isolation and characterisation of a novel glycopeptide antibiotic named biffamycin A, which harbours unprecedented 5-chloro-4-methoxy…

buff.ly

Big momentum from Obulytix 🚀 From joining END2AMR to shaping Europe’s AMR innovation landscape, the team is making strong moves against antimicrobial resistance. With leadership at BEAM Alliance and a feature in Euractiv, this is just the beginning. Read more ➡️ www.incate.net/building-mom...

Building momentum: recent milestones at Obulytix - INCATE

Obulytix has had an exciting start to the year, marked [...]

incate.net

What does it really take to be an entrepreneur? We’re bringing together a spinout founder, a startup enabler, and a seasoned entrepreneur to share real, no-fluff insights on the journey—challenges, mindset, and lessons learned. Join us ➡️ buff.ly/KeD3HI8 #Entrepreneurship #StartupLife #Innovation

What if part of the fight against AMR was hiding in our kitchens? New research suggests cinnamic acid (found in cinnamon) may help slow the spread of antibiotic resistance by disrupting bacterial gene transfer. Unexpected ideas like this deserve attention. Worth a read ➡️ buff.ly/JSQfvZY

💥 Our April newsletter is out! 💥 - New INCATE milestones - The Entrepreneurs Club is back! - Milestones from portfolio venture - ... and more! Read newsletter ➡ sh1.sendinblue.com/3g79gt1f9txp... Haven't you subscribed yet? Don't fall behind, subscribe here ➡ www.incate.net/newsletter/

Attention :DZIF, other DZGs, CARB-X members and INCATE portfolio planning early-phase clinical trials in translational research: DZIF PDU is hosting a free online workshop on 7 May, tailored for academic researchers working. 🗓 Registration: May 5 2026 Info & registration ➡️

PDU online workshop on early-phase clinical trials | German Center for Infection Research

PDU online workshop on early-phase clinical trials

buff.ly

Yesterday felt like a leap for INCATE. For the first time, our Selection Committee gathered in Munich at one of our industry partners facilities. Thank you to MSD Germany and all SC members for making it happen. Now… which ventures are next? Stay tuned

📢 One month left to apply for the ICARe 2026! 🗓️ Application deadline: June 21, 2026 📆 Course dates: October 10–18, 2026 📍 Les Pensières Center for Global Health, Annecy Spots are limited: secure yours now and be part of the future of antibiotic research. Info & application ➡️ www.icarecourse.org

We’re still here at #ESCMIDGlobal2026 ready to connect! No booth? No problem. The conversations are what matter most, and we’re all in. If you’ve got ideas, insights, challenges, or something exciting to share: we’re all ears! We are still around and would love to chat. Let’s make it happen!

The weekend is almost here, time for a good book. It’s been a while since we shared our community-built Phage reading list, so here’s what we’ve gathered so far. Have a title we should add? We’d love to hear it. Wishing you a relaxing, inspiring weekend

Big milestone in the fight against AMR 👏 Congrats BioVersys on the first patient, first visit in the Phase 3 BV100 trial — a key step toward new treatments for drug-resistant infections. At INCATE, we know how vital this progress is. ➡️ Read more: ir.bioversys.com/news/biovers...

We heard you 👀 With the long weekend coming up, many couldn’t join Entrepreneurs Club #6 — so we’ve moved it! 📅 May 28 | 🕔5pm CEST Join us for “What does it take to be an entrepreneur?” ! Save your spot ➡️ www.eventbrite.ch/e/entreprene... #EntrepreneursClub #StartupLife

Entrepreneurs Club #6: "What does it take to be an entrepreneur?"

The 6th INCATE Entrepreneurs Club brings together three compelling perspectives to uncover what defines entrepreneurship.

eventbrite.ch

🚀 ESCMID Global is almost here! No booth? No problem. INCATE will be in the heart of the action in Munich. Meet our team — Peter Seiler, Ina-Kristin Behrens, Holger Zimmermann & Sina Gerbach. Got ideas or insights? Let’s talk. 📩 comms@incate.net #ESCMIDglobal2026 #innovation #networking

🚀The Entrepreneurs Club is back! Join our 6th edition as 3 expert speakers share what it really takes to be an entrepreneur—through real experiences, insights, and lessons learned. Get inspired, gain practical tips, and hear fresh perspectives. Save your spot ➡️ www.eventbrite.ch/e/entreprene...

INCATE had the pleasure of joining “Antibiotic Resistance: Ways out of the Crisis” in Basel, represented by Holger, Peter, and Valéry. From cutting-edge research at the Biozentrum to engaging discussions with the AntiResist network, the event highlighted collaborative efforts to tackle AMR. #AMR

New paper dives into emerging perspectives that go beyond the usual narratives and highlight where innovation is most urgently needed. Read paper ➡️ buff.ly/mh53wW9 Curious to hear your thoughts. What stands out most to you?

💥 Our March newsletter is out! 💥 - AMR Conference insights - New INCATE milestones - Educational opportunities - ... and more! Read all about it in INCATE's Newsletter ➡ 6s05i.r.sp1-brevo.net/mk/mr/sh/6rq... Haven't subscribed yet? Don't fall behind, subscribe here ➡ www.incate.net/newsletter/

New research in International Journal of Infectious Diseases explores a twist in cystic fibrosis infections: key pathogens may have fewer defenses against bacteriophages, opening the door to entirely new treatment strategies. Read paper ➡️ www.ijidonline.com/article/S120... #CysticFibrosis

Phage Therapy in people with Cystic Fibrosis: a systematic review

Cystic fibrosis (CF) is an inherited disorder characterized by defective epithelial chloride and bicarbonate transport, resulting in abnormally viscous secretions and chronic airway obstruction [1]. F...

ijidonline.com

Big step in antibiotic innovation: Basilea Pharmaceutica has dosed the first volunteer in its Phase 1 study of BAL2420 This novel antibiotic targets LptA. 🚀 A key milestone in the fight against antimicrobial resistance. Read more ➡️ www.basilea.com#news_1594 #AMR #Antibiotics #Innovation

Basilea.com : Basilea

basilea.com

The PathoBlock Team is on the hunt for their next Life Science Manager! Ready to be part of the fight against AMR? Or know someone who is? Spread the word and help them find the perfect fit ➡️ www.linkedin.com/posts/incate...

📢 Applications for the Interdisciplinary Course on Antibiotics and Resistance (ICARe) are now open! 🗓️ Application deadline: June 21, 2026 📆 Course: October 10-18, 2026 📍 Les Pensières Center for Global Health, Annecy Info & application ➡️ buff.ly/c9b45Lr

Awesome news to start the week! The PROTON team from the @helmholtzhzi.bsky.social sky.social - an INCATE portfolio venture - has just won the concept phase of the Science4Life Venture Cup. Read it here ➡️ www.helmholtz-hzi.de/en/media-cen... #Startups #AntimicrobialResistance #Innovation

PROTON wins concept phase of Science4Life startup competition

The team behind the “PROTON” project from the Helmholtz Centre for Infection Research (HZI) was named the winner at the Science4Life Startup Competition.

helmholtz-hzi.de

What if penicillin could be deadly again, even to “surviving” bacteria? Some bacteria don’t resist antibiotics… they wait them out. But what if that survival mode is actually their weak spot? Are we underestimating the power of what we already have? Read here ➡️

Global response to antibiotic exposure reveals a critical role for nucleotide metabolism in high-level β-lactam tolerance - npj Antimicrobials and Resistance

npj Antimicrobials and Resistance - Global response to antibiotic exposure reveals a critical role for nucleotide metabolism in high-level β-lactam tolerance

buff.ly

What if Phages are not an alternative to antibiotics but their best partner? Phage–antibiotic combos are showing real promise against resistant infections. But: how do we pick the right phage? Dose it? Scale something so personalized? Read the Contagion_Live article ➡️

Phage-Antibiotic Combinations: What We Know, What We Don’t, and Where the Field Must Go Next | Contagion Live

Emerging preclinical, compassionate-use, and randomized trial data suggest phage-antibiotic combinations may benefit select patients with multidrug-resistant infections, yet critical gaps in…

buff.ly

2 days left to apply! Life science founders: ELSA by Life Science Factory is still open: don’t miss out! Get hands-on support with coaching, market validation, pitching & investor access. 📅 Apr–Jun 2026 | 📝 Deadline: Mar 20 Apply: lifescience-factory.com/en/program-d...